EVOGENE LTD. EVGN

$0.47 +1.97% at last close

Analyst Consensus

Recent Analyst Actions

DateFirmActionRatingPrice Target
2025-05-22
Lake StreetBen Klieve
Maintains Buy $5 → $4
2024-08-23
Lake StreetBen Klieve
Maintains Buy $30 → $12
2023-10-02
Alliance Global PartnersBen Haynor
Initiates coverage on Buy $19
2023-08-18
Lake StreetBen Klieve
Maintains Buy $20 → $30
2023-07-21
Roth MKMBrian Wright
Maintains Buy $10 → $60
2023-05-02
Lake StreetBen Klieve
Initiates coverage on Buy $20
2022-09-12
Aegis CapitalNathan Weinstein
Maintains Buy $100 → $80
2022-09-02
Roth MKMBrian Wright
Maintains Buy $60 → $30
2021-10-08
Roth CapitalBrian Wright
Initiates coverage on Buy $70
2021-07-29
Aegis CapitalNathan Weinstein
Initiates coverage on Buy $100
2020-12-01
Cantor FitzgeraldKristen Kluska
Initiates coverage on Overweight $90
2014-11-12
Credit Suisse
Maintains Outperform $24 → $22
2013-12-17
Deutsche Bank
Initiates coverage on Buy $22
2013-12-16
Credit Suisse
Initiates coverage on Outperform $25

Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.

Key Stats

Last Close
$0.47
Market Cap
$7.32 million
52-Week Range
$0.37 $1.50
Average Volume
252K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.